BioLASCO Taiwan Co., Ltd. (6662.TWO)
TWD 33.1
(-3.22%)
TWD 33.1
(-3.22%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 573.13 Million TWD | 0.61% |
| 2022 | 569.68 Million TWD | -0.8% |
| 2021 | 574.26 Million TWD | -2.57% |
| 2020 | 589.38 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 559.58 Million TWD | -2.36% |
| 2024 Q2 | 642.92 Million TWD | 14.89% |
| 2023 Q4 | 573.13 Million TWD | 2.76% |
| 2023 FY | 573.13 Million TWD | 0.61% |
| 2023 Q2 | 580.63 Million TWD | 1.49% |
| 2023 Q3 | 557.74 Million TWD | -3.94% |
| 2023 Q1 | 572.09 Million TWD | 0.0% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -347.6% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 80.243% |
| Level Biotechnology Inc. | 822.67 Million TWD | 30.332% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 13.778% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -4.445% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 85.281% |
| GlycoNex Incorporation | 1.55 Billion TWD | 63.09% |
| VBI | 452.1 Million TWD | -26.772% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 51.27% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 23.436% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -51.479% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 49.452% |
| Visgeneer Inc. | 397.17 Million TWD | -44.304% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 84.799% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 73.454% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 35.099% |
| Neith Corporation | 192.15 Million TWD | -198.272% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 90.593% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -679.166% |
| Enimmune corporation | 604.82 Million TWD | 5.239% |
| TaiRx, Inc. | 833.74 Million TWD | 31.257% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 81.428% |
| EirGenix Inc. | 11.16 Billion TWD | 94.866% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 66.529% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 84.065% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 45.44% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -90.391% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -116.559% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -29.907% |
| RBC Bioscience Corporation | 753.79 Million TWD | 23.966% |
| BiOptic Inc. | 613.77 Million TWD | 6.62% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 67.777% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 50.579% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 11.12% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 81.549% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -287.429% |
| NaviFUS Corp. | 490.53 Million TWD | -16.84% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 53.24% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 57.962% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -8.314% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 50.65% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 65.396% |
| AP Biosciences Inc | 890.75 Million TWD | 35.657% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 93.279% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -76.814% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 57.025% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 78.859% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 96.27% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -39.702% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -44.422% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 72.391% |
| TCI GENE Inc. | 1.16 Billion TWD | 50.843% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -94.561% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 57.96% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 39.142% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 17.941% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 85.505% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 85.007% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 53.397% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 89.772% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 46.033% |
| Acepodia, Inc. | 6.81 Billion TWD | 91.594% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 85.022% |